Type to search

New Roche Data for Evrysdi Show Improved Motor Function in Pre-symptomatic Babies after One Year and Confirm Safety Profile in Previously Treated People with Spinal Muscular Atrophy (SMA) | Pharmtech Focus
Medtronic Announces FDA Approval of its Next Generation Recharge-Free Spinal Cord Stimulation Platform | Pharmtech Focus